Syncona (LON:SYNC - Get Free Report)'s stock price traded up 0.4% during trading on Wednesday . The stock traded as high as GBX 102.40 ($1.30) and last traded at GBX 102.40 ($1.30). 299,750 shares changed hands during trading, a decline of 62% from the average session volume of 778,649 shares. The stock had previously closed at GBX 102 ($1.29).
Syncona Price Performance
The business has a 50-day simple moving average of GBX 106.40 and a two-hundred day simple moving average of GBX 112.65. The company has a quick ratio of 0.53, a current ratio of 1.00 and a debt-to-equity ratio of 64.05. The stock has a market capitalization of £657.07 million, a price-to-earnings ratio of 10,300.00 and a beta of 0.26.
About Syncona
(
Get Free Report)
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules.
Further Reading
Before you consider Syncona, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Syncona wasn't on the list.
While Syncona currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
